264 related articles for article (PubMed ID: 30207680)
1. Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway.
Zheng Y; Wu J; Shan W; Wu L; Zhou R; Liu M; Cui Y; Zhou M; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34039-34049. PubMed ID: 30207680
[TBL] [Abstract][Full Text] [Related]
2. The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of "easy uptake hard transcytosis" of ligand-modified nanoparticles in oral drug delivery.
Cui Y; Shan W; Zhou R; Liu M; Wu L; Guo Q; Zheng Y; Wu J; Huang Y
Nanoscale; 2018 Jan; 10(3):1494-1507. PubMed ID: 29303184
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
[TBL] [Abstract][Full Text] [Related]
4. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
[TBL] [Abstract][Full Text] [Related]
5. A novel ligand conjugated nanoparticles for oral insulin delivery.
Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
7. [Construction of Oral Insulin-Loaded Solid Lipid Nanoparticles and Their Intestinal Epithelial Cell Transcytosis Study].
Zheng YX; He Q; Xu M; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):570-576. PubMed ID: 34323033
[TBL] [Abstract][Full Text] [Related]
8. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs.
Xing L; Zheng Y; Yu Y; Wu R; Liu X; Zhou R; Huang Y
J Mater Chem B; 2021 Feb; 9(6):1707-1718. PubMed ID: 33496710
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
10. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
Xia CQ; Shen WC
Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
[TBL] [Abstract][Full Text] [Related]
11. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
12. Lipoic acid-mediated oral drug delivery system utilizing changes on cell surface thiol expression for the treatment of diabetes and inflammatory diseases.
Wu L; Xing L; Wu R; Fan X; Ni M; Xiao X; Zhou Z; Li L; Wen J; Huang Y
J Mater Chem B; 2024 Apr; 12(16):3970-3983. PubMed ID: 38563351
[TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
14. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors.
Liu X; Wu R; Li Y; Wang L; Zhou R; Li L; Xiang Y; Wu J; Xing L; Huang Y
Biomater Sci; 2021 Apr; 9(8):2903-2916. PubMed ID: 33599658
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.
Liu L; Zhou C; Xia X; Liu Y
Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360
[TBL] [Abstract][Full Text] [Related]
19. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
20. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
